Top Markets
Coin of the day
Vivimed Labs Ltd. Vivimed Labs Ltd.

Vivimed Labs Ltd.

VIVIMEDLAB
Pozycja w akcjach #35079
Established in 1988 and headquartered in Hyderabad, India, Vivimed Labs... Established in 1988 and headquartered in Hyderabad, India, Vivimed Labs Limited, along with its associated entities, is an international manufacturer and supplier of diverse products, including active pharmaceutical ingredients (APIs), finished drug formulations, specialized chemicals, and consumer-branded remedies. Its global presence extends across markets such as India, Mexico, Spain, and Hungary, among others. The company's operations are divided into two core segments: the Pharmaceutical Business and the Specialty Chemicals Business. Within its Pharmaceutical division, Vivimed Labs supplies APIs and crucial intermediates to both generic and ethical pharmaceutical companies. It also develops and markets proprietary branded formulations catering to therapeutic areas like ophthalmology, nutraceuticals, dermatology, and pain relief. Additionally, it provides contract manufacturing services for a variety of dosage forms, including capsules, tablets, syrups, liquids, nasal sprays, and ointments. A notable product is Favulous, manufactured for the treatment of mild to moderate COVID-19 cases. The Specialty Chemicals segment boasts a broad portfolio. This includes Jarocol-branded hair dye intermediates essential for permanent, semi-permanent, and temporary hair coloring systems, alongside oxidation dye couplers, bases, and direct and basic dyes. It also produces Reversacol-branded photochromic dyes and antimicrobial agents utilized in applications ranging from plastic additives to antibacterial handwashes. Furthermore, the company manufactures photographic chemicals, such as black and white developers and antifog additives, for medical and industrial X-ray imaging, consumer photography, and graphic arts litho-plate production. Collectively, Vivimed Labs' offerings find extensive application in the home, personal, and industrial care sectors.
Cena akcji
$0.05418616
Ostatnia synchronizacja: 2026-08-14
Kapitalizacja rynkowa
$4.49M
Zmiana (1 dzień)
-1.01%
Zmiana (1 rok)
-4.01%
Kraj
IN
Handel Vivimed Labs Ltd. (VIVIMEDLAB)

Kategoria

Cena VIVIMEDLAB z kapitalizacją rynkową B
Vivimed Labs Ltd. Vivimed Labs Ltd.
VIVIMEDLAB
$0.05418616
Kapitalizacja rynkowa Vivimed Labs Ltd.(VIVIMEDLAB)
Kapitalizacja rynkowa: $4.49M
Na dzień August 2026 spółka Vivimed Labs Ltd. ma kapitalizację rynkową wynoszącą $4.49M. Według naszych danych, czyni to Vivimed Labs Ltd. 35079th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Vivimed Labs Ltd. od 2005 do 2026
VIVIMEDLAB w porównaniu do 5 najpopularniejszych stocks
Cena za VIVIMEDLAB Aktywa B Kapitalizacja rynkowa B Wyniki
Vivimed Labs Ltd. Vivimed Labs Ltd.
$65,750.89 $4.49M
$5.452T +121,342,494.78%
Vivimed Labs Ltd. Vivimed Labs Ltd.
$54,150.77 $4.49M
$4.490T +99,934,587.44%
Vivimed Labs Ltd. Vivimed Labs Ltd.
$50,199.67 $4.49M
$4.162T +92,642,879.04%
Vivimed Labs Ltd. Vivimed Labs Ltd.
$44,337.61 $4.49M
$3.676T +81,824,506.30%
Vivimed Labs Ltd. Vivimed Labs Ltd.
$34,167.20 $4.49M
$2.833T +63,055,124.40%